Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Sci Rep ; 10(1): 17545, 2020 10 16.
Article in English | MEDLINE | ID: mdl-33067519

ABSTRACT

Little is known about gender-specific reporting of adverse events (AEs) associated with antidiabetic drugs. This study was to assess the gender-related difference in AEs reporting associated with antidiabetic agents. The number of antidiabetic drug-AE pairs associated was identified using the Korea Adverse Event Reporting System database. Prevalence of diabetes was estimated using the Health Insurance Review and Assessment Service-National Patients Sample database. Reporting rate per 10,000 people was calculated by dividing drug-AE pairs with the number of antidiabetic drug users by gender. Gender difference was presented with risk ratio (reporting rate ratio) of women to men. Antidiabetic agent-associated AEs were more frequently reported by women than men throughout body organs and drug classes. 13 out of 17 system organ class level disorders with significant gender differences were reported more often by women than men. By drug class, gender-specific reporting rates were observed in most of the drug classes, especially in newer classes such as glucagon-like peptide-1 analog (GLP1-RA), sodium glucose co-transporter-2 inhibitor (SGLT2i), and thiazolidinedione (TZD). Looking into preferred term level for each drug class, women dominated the reports of class-specific AEs of newer antidiabetic drugs such as urinary tract/genital infection (all reported by women) in SGLT2i, edema in TZD (risk ratio (RR) 12.56), and hyperglycemia in insulin users (RR 15.35). Gender differences in antidiabetic-associated AE reporting often attributed to women. Explanations for these different report levels by gender should be further investigated.


Subject(s)
Adverse Drug Reaction Reporting Systems , Diabetes Mellitus/drug therapy , Hypoglycemic Agents/adverse effects , Sex Factors , Adult , Aged , Aged, 80 and over , Databases, Factual , Female , Glucagon-Like Peptide-1 Receptor/metabolism , Humans , Insulin/metabolism , Male , Middle Aged , Republic of Korea/epidemiology , Risk , Sodium-Glucose Transporter 2 Inhibitors/adverse effects , Thiazolidinediones/adverse effects
2.
Sci Rep ; 6: 25726, 2016 05 10.
Article in English | MEDLINE | ID: mdl-27160066

ABSTRACT

TonEBP is a key transcriptional activator of M1 phenotype in macrophage, and its high expression is associated with many inflammatory diseases. During the progression of the inflammatory responses, the M1 to M2 phenotypic switch enables the dual role of macrophages in controlling the initiation and resolution of inflammation. Here we report that in human and mouse M1 macrophages TonEBP suppresses IL-10 expression and M2 phenotype. TonEBP knockdown promoted the transcription of the IL-10 gene by enhancing chromatin accessibility and Sp1 recruitment to its promoter. The enhanced expression of M2 genes by TonEBP knockdown was abrogated by antagonism of IL-10 by either neutralizing antibodies or siRNA-mediated silencing. In addition, pharmacological suppression of TonEBP leads to similar upregulation of IL-10 and M2 genes. Thus, TonEBP suppresses M2 phenotype via downregulation of the IL-10 in M1 macrophages.


Subject(s)
Immunomodulation , Interleukin-10/metabolism , NFATC Transcription Factors/metabolism , Animals , Antineoplastic Agents/pharmacology , Chromatin/metabolism , Humans , Immunomodulation/drug effects , Interleukin-10/genetics , Interleukin-4/metabolism , Macrophages/drug effects , Macrophages/metabolism , Mice , Models, Biological , NFATC Transcription Factors/genetics , Naphthoquinones/pharmacology , Phenotype , Promoter Regions, Genetic/genetics , RAW 264.7 Cells , Signal Transduction/drug effects , Sp1 Transcription Factor/metabolism , Tissue Donors , Transcription, Genetic/drug effects
3.
J Prev Med Public Health ; 40(3): 233-8, 2007 May.
Article in Korean | MEDLINE | ID: mdl-17577079

ABSTRACT

OBJECTIVES: We aimed to assess the relationship between long-term exposure to air pollution and lung cancer in the Republic of Korea. METHODS: Using the Annual Report of Ambient Air Quality in Korea, Annual Report of National Cancer Registration, and Annual Report on the Cause of Death Statistics, we calculated the standardized mortality ratio (SMR) and standardized incidence ratio (SIR) of lung cancer for both sexes in 74 areas from 7 Korean metropolitan cities. We performed random intercept,Poisson regression using empirical Bayes method. RESULTS: Both SMRs and SIRs in the 7 metropolitan cities were higher in women than in men. Mean SIRs were 99.0 for males and 107.0 for females. The association between PM10 and lung cancer risk differed according to gender. PM10 was not associated with the risk of lung cancer in males, but both incidence and mortality of lung cancer were positively associated with PM10 in females. The estimated percentage increases in the rate of female lung cancer mortality and incidence were 27% and 65% at the highest PM10 category (>or=70 microgram/m3), compared to the referent category (<50 microgram/m3). CONCLUSIONS: Long-term exposure to PM10 was significantly associated with female lung cancer incidence in 7 Korean metropolitan cities. Further study is undergoing to estimate the relative risk of PM10 using multi-level analysis for controlling individual and regional confounders such as smoking and socioeconomic position.


Subject(s)
Air Pollution/adverse effects , Environmental Exposure/adverse effects , Lung Neoplasms/epidemiology , Female , Humans , Korea/epidemiology , Lung Neoplasms/mortality , Male , Sex Distribution , Urban Health
SELECTION OF CITATIONS
SEARCH DETAIL
...